Research Reports
Macleods Pharmaceuticals Ltd Unlisted Shares
Macleods Pharmaceuticals Ltd company logo

Macleods Pharmaceuticals Ltd Share Price

PHYSICAL
PUBLIC LIMITED

Price Chart

1W
1M
1Y
MAX
High

₹33,000

Low

₹505

Return

-0.06%

Macleods Pharmaceuticals Ltd Essentials

As of April 05, 2026, Macleods Pharmaceuticals Ltd, Unlisted Shares are trading at ₹505.00 per share and face value is ₹1.00/share, with a 52-week high of ₹505.00 and 52-week low of ₹505.00. The minimun lot size is None shares, and the shares are traded on .
ISIN
info icon
INE05JF01026
Face Value
info icon
1
Total Shares
info icon
59,88,20,400
Market Cap
info icon
30,240.43 Cr
Profit After Tax
info icon
1,328.26 Cr
Total Revenue
info icon
8,207.09 Cr
P/E
info icon
24.62
P/B
info icon
6.85
Sector
info icon
Health Care
Sub-sector
info icon
Pharmaceuticals
Category
info icon
Mid Cap
Cashflow - Operations
info icon
1,439.59 Cr

About Macleods Pharmaceuticals Ltd

Company Overview:
  • Macleods Pharmaceuticals is engaged in the development, manufacturing, marketing, and distribution of various formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
  • Macleods Pharmaceuticals caters to therapies such as antituberculosis, antimalarials, antiretrovirals, antibacterial, antidiabetics, antihypertensives, and antiasthmatics. The company is also known for the number of WHO-pre qualified medicines, used in the treatment of HIV/AIDS, Malaria, Tuberculosis (TB), and opportunistic infections.
  • The company has the highest number of WHO pre-qualified products globally with 65 registrations, and the highest number of WHO pre-qualified anti-TB product registrations with 32 registrations.
  • Macleods Pharmaceuticals has a strong international presence and exports its products to over 100 countries worldwide. The company has subsidiaries and offices in several countries including the United States, the United Kingdom, Spain, South Africa, Russia, Malaysia, and Ukraine, etc.
  • The company had a portfolio of 595 brands in the Indian Pharmaceutical Market in FY21 with 2 brands in the top 100 Indian brands. The company had successfully scaled new brands in short durations, with the brand Panderm++ crossing ₹ 1 bn in domestic sales. 
  • The company also ranked 1st in the molecular group of Clobetasol, Miconazole, and Neomycin in the Indian Pharmaceutical Market in terms of sales. The company launched new brands Vildamac and Vildamac M in the anti-diabetic market.
  • Macleods Pharma has the state of the art manufacturing facilities that comply with international quality standards. The company has manufacturing units spread across India such as Daman, Baddi, Sikkim, Indore, Palghar, Dahej, and Sarigam.
  • Macleods Pharmaceuticals adheres to regulatory guidelines and complies with regulations set by regulatory authorities in the countries where it operates. This includes compliance with regulatory bodies such as the U.S. Food and Drug Administration (FDA), the Medicines and Healthcare Products. Regulatory Agency (MHRA) in the UK, and others.
  • Macleods Pharmaceuticals was founded in the year 1986 by Dr. R. A. Agarwal along with his two brothers - Girdhari Lal and Banwari Lal. The company got incorporated as a Public Limited company on 5th June in the year 1989 and is the seventh largest pharma company in India with a sales team of more than 4,900 medical representatives.

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

Macleods Pharmaceuticals Ltd Media

News
Articles
Videos
Macleods Pharma Wins Legal Battle Over Linagliptin Patent
Macleods Pharma Wins Legal Battle Over Linagliptin Patent
20 Jan 2025
Medical Dialogues
Macleods Pharma recalls 10,000 bottles of anti-bacterial medication in US over labeling error
Macleods Pharma recalls 10,000 bottles of anti-bacterial medication in US over labeling error
25 Jan 2023
Live Mint
Macleods Pharmaceuticals' purchases Juhu property for Rs 3.32 billion
Macleods Pharmaceuticals' purchases Juhu property for Rs 3.32 billion
14 Sep 2022
Construction World

Macleods Pharmaceuticals Ltd

₹ 505

cartIcon